CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/07/2022
Back to search
Official data from USPTO
RO5
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
14
Latest update
03/07/2022
Classification
Registered
Trademark type
Combined
Nice classes
42
Filing date
04/23/2021
Registration date
01/25/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/25/2022
Last transaction
01/25/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
12/06/2020
First use in commerce
12/06/2020
Drawing code
3
Owner type
03
Owner location
Dallas, TX, US
Examiner
RINKER, ANTHONY
Law office
L20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of Capital letter "R" adjacent to a hexagonal-shaped "O", with the number "5" near the upper right of the hexagonal-shaped "O".
Holders and representatives
Holders
Ro5, Inc.
Ro5, Inc.
Representatives
J. Pat Heptig HEPTIG LAW GROUP, LTD.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical research services; pharmaceutical research services; pharmaceutical research and development services; medical and scientific research in the field of machine learning and models to evaluate drug compounds pharmacological properties; medical and scientific research services in the field of machine learning models to evaluate bioactivity and pharmacological properties of drug compounds; medical and scientific research services in the field of machine learning models to generate and evaluate drug compounds for specific pharmacological and bioactivity effects and results; medical and scientific research services in the field of machine learning models to evaluate drug compounds and their efficacy and side effects for purposes of clinical trials
Publications
History of USPTO decisions and trademark events.
14 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/07/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/07/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/07/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/07/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
01/25/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/09/2021
PUBO
PUBLISHED FOR OPPOSITION
11/09/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/20/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/07/2021
DOCK
ASSIGNED TO EXAMINER
10/06/2021
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/30/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/29/2021
NWAP
NEW APPLICATION ENTERED
04/27/2021
Continuous trademark protection
Get notified about every new filing that threatens RO5 or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.